Medicamen Organics Limited IPO Details
| Detail | Description |
|---|---|
| IPO Date | June 21, 2024 to June 25, 2024 |
| Listing Date | - |
| Face Value | ₹ 10 per share |
| Price Band | ₹ 32 to ₹ 34 per share |
| Lot Size | 4,000 Shares |
| Total Issue Size | 31,00,000 shares (aggregating up to ₹ 10.54 Cr) |
| Fresh Issue | 31,00,000 shares (aggregating up to ₹ 10.54 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 86,00,000 |
| Share holding post issue | 1,17,00,000 |
| Market Maker portion | 1,72,000 shares |
About Medicamen Organics Limited IPO
Medicamen Organics Limited is engaged in developing, manufacturing and distributing a broad range of pharmaceutical dosages including generic dosages in the form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer. They have a track record of operating a B2B model which covers the contract manufacturing model. Their manufacturing facilities are capable of producing pharmaceutical formulations and products and have a fully equipped quality control department with experienced and qualified staff to facilitate a smooth manufacturing process. Medicamen Organics IPO is a book-built issue of Rs 10.54 crores.
The issue is entirely a fresh issue of 31 lakh shares. Medicamen Organics IPO opens for subscription on June 21, 2024 and closes on June 25, 2024. The allotment for the Medicamen Organics IPO is expected to be finalized on Wednesday, June 26, 2024. Medicamen Organics IPO price band is set at ₹32 to ₹34 per share. The minimum lot size for an application is 4000 Shares. GYR Capital Advisors Private Limited is the book-running lead manager of the Medicamen Organics IPO, while Kfin Technologies Limited is the registrar for the issue. The market maker for Medicamen Organics IPO is Giriraj Stock Broking.
Objectives of Medicamen Organics IPO
The company proposes to utilize the Net Proceeds from the Issue towards the following objectives:
- 1. Funding of expenses proposed to be incurred towards Product registration in the international markets;
- 2. Plant updation and increase in production capacity;
- 3. Funding working capital requirements of our Company; and
- 4. General Corporate Purposes.
Medicamen Organics IPO Review
The company is operating in a highly competitive and fragmented segment of Pharma products. It posted average financial performance for the reported periods with a boosted bottom line for FY24. Based on FY24 earnings, the issue appears fully priced. Well-informed investors may park moderate funds for long-term rewards.
Medicamen Organics Limited IPO Financial Information
Latest Revenue
2,528.96
₹ Crore
Profit After Tax
240.41
₹ Crore
Net Worth
1,518.40
₹ Crore
Total Borrowing
1,265.65
₹ Crore
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Total Borrowing | ||||
|---|---|---|---|---|---|---|---|---|---|
| 31 Mar 2024 | 3,858.07 | 2,528.96 | 240.41 | 1,518.40 | 1,265.65 | ||||
| 31 Mar 2023 | 3,211.98 | 2,296.24 | 95.78 | 1,518.40 | 1,179.50 | ||||
| 31 Mar 2022 | 2,707.21 | 2,118.67 | 9.23 | 755.92 | 1,024.57 | ||||
| 31 Mar 2021 | 2,634.37 | 2,505.96 | 29.81 | 746.72 | 958.97 | ||||
| Amount in ₹ Crore | |||||||||
Medicamen Organics Limited Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 19.90% |
| ROCE | 14.50% |
| Debt/Equity | 0.83RoNW |
| RoNW | 15.83 |
| P/BV | 2.39 |
| PAT Margin (%) | 9.51 |
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The India IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
Download regulatory filings
Medicamen Organics Limited IPO Timeline
| IPO Open Date | Friday, June 21, 2024 |
| IPO Close Date | Tuesday, June 25, 2024 |
| Basis of Allotment | Wednesday, June 26, 2024 |
| Initiation of Refunds | Thursday, June 27, 2024 |
| Credit of Shares to Demat | Thursday, June 27, 2024 |
| Listing Date | Friday, June 28, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on June 25, 2024 |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Retail (Min) | 1 | 4000 | ₹136,000 |
| Retail (Max) | 1 | 4000 | ₹136,000 |
| HNI (Min) | 2 | 8,000 | ₹272,000 |